Sunday 11 October 2026 Export all EQ data to Excel Powerpack

Equillium, Inc.

EQ Healthcare Biotechnology

Equillium, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $41.1 million, up 13.9% from fiscal 2023. In the quarter to June 2026, revenue fell 52.3%, EPS grew 75.0% and free cash flow fell 38.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.

1.41 0.03 −2.08%
Market cap
$91.3M
P/E
0.0×
Fwd P/E
−5.2×
Dividend yield
—
F-score
3/9
Altman Z
−6.75
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cash and Short Term Investments
30.28 22.58 40.87 71.02 80.71 82.16 53.14 65.91 7.10
Receivables
— — 3.74 2.84 — — — — —
Total current assets
31.04 24.98 49.35 76.74 83.37 85.17 55.43 67.10 7.15
Property, Plant, Equpment (Net)
0.16 0.26 0.32 0.39 0.24 0.24 0.09 0.06 0.00
Long-term assets (Other)
0.03 — 0.07 0.10 0.15 0.02 0.02 — —
Total non-current assets
0.85 0.63 1.18 1.69 2.04 0.25 0.11 0.06 0.00
Total Assets
31.89 25.60 50.53 78.42 85.41 85.43 55.54 67.16 7.15
Accounts Payable
0.76 2.68 4.71 3.98 1.23 2.77 1.87 1.12 0.24
Accrued Expenses
1.82 3.48 6.70 7.24 5.89 2.81 2.01 0.91 0.33
Current Part of Debt
— — — 5.71 1.43 1.67 — — —
Current Revenue (Deferred)
— — 15.73 14.70 — — — — —
Total current liabilities
2.93 6.36 27.57 32.04 8.92 7.25 3.88 2.03 0.57
Long Term Debt (Total)
— — — 3.24 8.75 8.28 9.68 — 8.06
Non-current Revenue (Deferred)
— — — 10.38 — — — — —
Non-current Liabilities (Other)
— — — — — 0.05 0.13 0.20 0.78
Total non-current liabilities
0.36 0.19 0.38 14.44 9.99 8.33 9.81 0.20 8.83
Total liabilities
3.29 6.54 27.96 46.48 18.90 15.57 13.69 2.23 9.40
Additional Paid In Capital
244.43 212.08 208.17 204.27 176.62 141.07 82.94 80.44 0.01
Common Stock (Net)
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings
(216.20) (193.81) (185.74) (172.40) (109.98) (70.92) (41.11) (15.51) (2.26)
Common Equity (Total)
28.60 19.06 22.57 31.94 66.51 69.85 41.85 64.94 (2.25)
Shareholders Equity (Total)
28.60 19.06 22.57 31.94 66.51 69.85 41.85 64.94 (2.25)
Shareholders Equity and Liabilities (Total)
31.89 25.60 50.53 78.42 85.41 85.43 55.54 67.16 7.15
Shares (Common)
61.46 35.56 35.26 34.41 29.46 24.75 17.43 17.38 10.71
Shareholders Equity (Tangible)
28.60 19.06 22.57 31.94 66.51 69.85 41.85 64.94 (2.25)
Net Debt
(30.28) (22.57) (40.87) (62.07) (70.53) (72.22) (43.46) (65.91) 0.96
Total Debt
— — — 8.95 10.18 9.94 9.68 — 8.06

Fold the line items

In millions of $ except per-share values · columns are period end dates